Market Survey On Diagnostics
Partnering Terms and Agreements:
The
Diagnostics Partnering Terms and Agreements report provides comprehensive
understanding and unprecedented access to the diagnostic partnering agreements
entered into by the worlds leading healthcare companies.
The report
provides a detailed understanding and analysis of how and why companies enter
diagnostic partnering deals. The majority of deals are development stage
whereby the licensee obtains a right or an option right to license the
licensors diagnostic technology or product candidates. These deals tend to be
multicomponent, starting with collaborative R&D, and commercialization of
outcomes.
To Read the
Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis-details/drug-delivery-partnering-terms-and-agreements
Understanding
the flexibility of a prospective partner’s negotiated deals terms provides
critical insight into the negotiation process in terms of what you can expect
to achieve during the negotiation of terms. Whilst many smaller companies will
be seeking details of the payments clauses, the devil is in the detail in terms
of how payments are triggered – contract documents provide this insight where
press releases and databases do not.
The
initial chapters of this report provide an orientation of diagnostics
dealmaking and business activities. Chapter 1 provides an introduction to the
report, whilst chapter 2 provides an overview of the trends in diagnostics
dealmaking since 2007, including details of average headline, upfront,
milestone and royalty terms.
Chapter 3
provides a review of the leading diagnostics deals since 2007. Deals are listed
by headline value, signed by big pharma, big biotech and and most active of all
biopharma companies. Where the deal has an agreement contract published at the
SEC a link provides online access to the contract.
Chapter 4
provides a comprehensive listing of the top 50 big pharma companies with a
brief summary followed by a comprehensive listing of diagnostics deals, as well
as contract documents available in the public domain. Where available, each
deal title links via Weblink to an online version of the actual contract document,
providing easy access to each contract document on demand.
Chapter 5
provides a comprehensive listing of the top 50 big biotech companies where
diagnostic deals are announced with a brief summary, as well as contract
documents available in the public domain. Where available, each deal title
links via Weblink to an online version of the actual contract document,
providing easy access to each contract document on demand.
Chapter 6
provides a comprehensive and detailed review of diagnostics partnering deals
signed and announced since January 2007, where a contract document is available
in the public domain. The chapter is organized by stage of development at
signing, deal type (collaborative R&D, co-promotion, licensing etc), and
specific therapy focus. Each deal title links via Weblink to an online version
of the deal record and where available, the contract document, providing easy
access to each contract document on demand.
Chapter 7
provides a comprehensive and detailed review of diagnostics partnering deals
signed and announced since January 2007. The chapter is organized by specific
diagnostics technology type in focus. Each deal title links via Weblink to an
online version of the deal record and where available, the contract document,
providing easy access to each contract document on demand.
The report also
includes numerous tables and figures that illustrate the trends and activities
in diagnostics partnering and dealmaking since 2007.
In
conclusion, this report provides everything a prospective dealmaker needs to
know about partnering in the research, development and commercialization of
diagnostics technologies and products.
Report scope
Diagnostics
Partnering Terms and Agreements is intended to provide the reader with an
in-depth understanding of the diagnostic trends and structure of deals entered
into by leading companies worldwide.
Diagnostics
Partnering Terms and Agreements includes:
Trends in diagnostic dealmaking in the
biopharma industry since 2007
Analysis of diagnostic deal structure
Case studies of real-life diagnostic deals
Access to over 3,700 diagnostic deals
The leading diagnostic deals by value since
2007
Most active diagnostic dealmakers since
2007
The leading diagnostic partnering resources
In
Diagnostics Partnering Terms and Agreements , the available contracts are
listed by:
Headline value
Stage of development at signing
Deal component type
Specific therapy target
Each deal
title links via Weblink to online deal records of actual diagnostics partnering
deals as disclosed by the deal parties. In addition, where available, records
include contract documents as submitted to the Securities Exchange Commission
by companies and their partners.
About Us
MarketResearchReports.Biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and
money for our clients. We are a one stop solution for all your research needs,
our main offerings are syndicated research reports, custom research,
subscription access and consulting services. We serve all sizes and types of
companies spanning across various industries.
Contact
M/s Sheela
90 Sate
Street, Suite 700
Albany, NY
12207
Tel:
+1-518-618-1030
USA –
Canada Toll Free: 866-997-4948
Blog: http://industry-research-reports.blogspot.com/
No comments:
Post a Comment